石药景峰
(000908)
| 流通市值：58.86亿 | | | 总市值：117.71亿 |
| 流通股本：8.80亿 | | | 总股本：17.60亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 202,394,681.3 | 107,542,539.26 | 378,112,342.1 | 271,855,932.89 |
| 营业收入 | 202,394,681.3 | 107,542,539.26 | 378,112,342.1 | 271,855,932.89 |
| 二、营业总成本 | 203,062,908.88 | 102,663,961.1 | 443,092,815.97 | 303,257,473.56 |
| 营业成本 | 70,497,730.29 | 33,076,348.32 | 140,319,487.67 | 96,126,899.95 |
| 税金及附加 | 3,896,777.45 | 1,354,139.35 | 7,244,073.42 | 5,279,675.92 |
| 销售费用 | 87,664,998.49 | 47,981,482.68 | 164,536,351.19 | 118,110,295.68 |
| 管理费用 | 28,724,966.77 | 15,858,859.52 | 89,991,108.49 | 58,366,542.98 |
| 研发费用 | 10,094,974.07 | 3,111,688.8 | 11,002,370.45 | 7,735,744.64 |
| 财务费用 | 2,183,461.81 | 1,281,442.43 | 29,999,424.75 | 17,638,314.39 |
| 其中:利息费用 | 3,494,992.3 | 1,327,836.83 | 30,370,203.22 | 14,195,204.84 |
| 其中:利息收入 | 1,338,969.09 | 38,535.71 | 417,454.56 | 153,809.88 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | 0 | - |
| 加:投资收益 | 6,600,274.19 | -202,475.21 | 36,237,362.46 | 1,395,768.83 |
| 资产处置收益 | 294,675.73 | 301,189.74 | -2,773,135.77 | -211,045.09 |
| 资产减值损失(新) | 943,954.12 | 416,522.45 | -28,253,844.24 | 503,546.56 |
| 信用减值损失(新) | -2,182,036.24 | -55,364.21 | -5,317,414.14 | -653,415.27 |
| 其他收益 | 5,286,350.21 | 1,102,520.26 | 7,094,906.32 | 5,744,720.97 |
| 四、营业利润 | 10,274,990.43 | 6,440,971.19 | -57,992,599.24 | -24,621,964.67 |
| 加:营业外收入 | 1,238,726.96 | 491,138.45 | 9,301,892.32 | 565,184.08 |
| 减:营业外支出 | 522,805.4 | 149,161.74 | 28,912,458.53 | 17,269,920.26 |
| 五、利润总额 | 10,990,911.99 | 6,782,947.9 | -77,603,165.45 | -41,326,700.85 |
| 减:所得税费用 | 2,873,594.5 | 2,071,346.71 | 1,444,043.13 | 1,948,601.23 |
| 六、净利润 | 8,117,317.49 | 4,711,601.19 | -79,047,208.58 | -43,275,302.08 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 8,117,317.49 | 4,711,601.19 | -79,047,208.58 | -43,275,302.08 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 5,868,878.59 | 3,670,161.2 | -80,889,814.6 | -44,564,898.82 |
| 少数股东损益 | 2,248,438.9 | 1,041,439.99 | 1,842,606.02 | 1,289,596.74 |
| 扣除非经常损益后的净利润 | -6,875,837.57 | 1,942,082.39 | -102,957,574.16 | -34,272,754.53 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0 | 0 | -0.09 | -0.05 |
| (二)稀释每股收益 | 0 | 0 | -0.09 | -0.05 |
| 八、其他综合收益 | 278,116.01 | 114,285.08 | 155,805.52 | 130,832.58 |
| 归属于母公司股东的其他综合收益 | 124,429.35 | 58,285.39 | 79,460.82 | 66,724.62 |
| 九、综合收益总额 | 8,395,433.5 | 4,825,886.27 | -78,891,403.06 | -43,144,469.5 |
| 归属于母公司股东的综合收益总额 | 5,993,307.94 | 3,728,446.59 | -80,810,353.78 | -44,498,174.2 |
| 归属于少数股东的综合收益总额 | 2,402,125.56 | 1,097,439.68 | 1,918,950.72 | 1,353,704.7 |
| 公告日期 | 2026-08-21 | 2026-04-29 | 2026-04-29 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |